Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00746616 · ClinicalTrials.gov registry record · Phase 3
Durom(R) Hip Resurfacing System Multicenter Trial
A Phase 3 study, sponsored by Zimmer Biomet.
- Completed
- Registry status
- Phase 3
- Development phase
- 40
- Enrollment target
NCT00746616 is a Phase 3 study that has completed, run by Zimmer Biomet. The registered enrollment target is 40 participants.
The verdict
NCT00746616, a Phase 3 study, has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of the study is to gather clinical information on the safety and efficacy of the resurfacing devices in the young, active patient with advanced hip disease. Study enrollment has been temporarily suspended due to a change in the surgical technique.
Interventions
- DEVICE Durom Hip Resurfacing System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-06 |
| Est. Completion | 2011-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00746616
The ClinicalTrials.gov registry entry for NCT00746616 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Durom Hip Resurfacing System is the first listed.
NCT00746616 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00746616 about?
NCT00746616 is a clinical study titled "Durom(R) Hip Resurfacing System Multicenter Trial". The purpose of the study is to gather clinical information on the safety and efficacy of the resurfacing devices in the young, active patient with advanced hip disease. Study enrollment has been temporarily suspended due to a change in the surgical technique.
What is the current status of trial NCT00746616?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 2007-06. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00746616?
The interventions under investigation include: Durom Hip Resurfacing System (DEVICE).
Who is sponsoring clinical trial NCT00746616?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.